InsidersTradesSigma
Total declarations
Companies
▲ Purchases (36 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
36
Disclosed sells
2
T+90 hit rate
60%
T+90 mean return
+24.4%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Whitmore Bradford T, Director. Officer active across 4 companies, notably Ultralife CORP. Aggregated, 40 filings have been published. Breakdown: 36 buys · 2 sells. Total volume traded: €42.9m. History available since 7 May 2021. The latest transaction was disclosed on 12 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Whitmore Bradford T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations40 total
33,741 shares@ US$5.96630.18% mcap11.8% of flowCommon StockSEC:0000933430-26-000002:0
Canonical exit: 10 Jun 2026 (T+90)
9,530 shares@ US$5.62570.048% mcap3.1% of flowCommon StockSEC:0000933430-25-000011:0
Canonical exit: 12 Mar 2026 (T+90)
53,900 shares@ US$4.970611.8% of flowCommon StockSEC:0000933430-25-000010:0
Canonical exit: 17 Feb 2026 (T+90)
15,898 shares@ US$6.56480.094% mcap6.0% of flowCommon StockSEC:0000933430-25-000009:0
Canonical exit: 17 Nov 2025 (T+90)
10,000 shares@ US$7.63923.8% of flowCommon StockSEC:0000933430-25-000006:0
Canonical exit: 11 Sept 2025 (T+90)
2,500,000 shares@ US$4.20100.0% of flowCommon StockSEC:0000933430-25-000004:0
Canonical exit: 27 Aug 2025 (T+90)
11,980 shares@ US$5.40722.9% of flowCommon StockSEC:0000933430-25-000003:0
Canonical exit: 21 Aug 2025 (T+90)
8,957 shares@ US$5.39831.9% of flowCommon StockSEC:0000933430-25-000002:0
Canonical exit: 11 Aug 2025 (T+90)
15,000,000 shares0Common StockSEC:0000933430-24-000007:0
2,791,725 shares@ US$0.401.7% of flowCommon StockSEC:0000933430-24-000002:0
Canonical exit: 8 May 2024 (T+90)
444,444 shares@ US$1.3531.9% of flowCommon StockSEC:0000933430-24-000001:0
Canonical exit: 7 May 2024 (T+90)
8,877 shares@ US$6.82712.5% of flowCommon StockSEC:0000933430-23-000017:0
Canonical exit: 5 Mar 2024 (T+90)
3,200 shares@ US$7.11960.9% of flowCommon StockSEC:0000933430-23-000016:0
Canonical exit: 25 Feb 2024 (T+90)
600 shares@ US$0.6850.0% of flowCommon StockSEC:0000933430-23-000013:0
Canonical exit: 28 Jan 2024 (T+90)
10,171 shares@ US$7.03623.0% of flowCommon StockSEC:0000933430-23-000014:0
Canonical exit: 28 Jan 2024 (T+90)
5,659 shares@ US$10.02092.4% of flowCommon StockSEC:0000933430-23-000010:0
Canonical exit: 12 Dec 2023 (T+90)
44,198 shares@ US$0.91860.1% of flowCommon StockSEC:0000933430-23-000009:0
Canonical exit: 19 Nov 2023 (T+90)
13,401 shares@ US$4.72352.6% of flowCommon StockSEC:0000933430-23-000008:0
Canonical exit: 10 Sept 2023 (T+90)
5,964 shares@ US$4.40011.1% of flowCommon StockSEC:0000933430-23-000007:0
Canonical exit: 31 Aug 2023 (T+90)
8,200 shares@ US$1.17640.0% of flowCommon StockSEC:0000933430-23-000005:0
Canonical exit: 28 Aug 2023 (T+90)
6,500 shares@ US$4.29251.1% of flowCommon StockSEC:0000933430-23-000006:0
Canonical exit: 28 Aug 2023 (T+90)
53,040 shares@ US$0.77150.1% of flowCommon StockSEC:0000933430-23-000004:0
Canonical exit: 15 Aug 2023 (T+90)
4,553 shares@ US$3.9720.7% of flowCommon StockSEC:0000933430-23-000003:0
Canonical exit: 7 Aug 2023 (T+90)
5,562 shares@ US$4.07090.9% of flowCommon StockSEC:0000933430-23-000002:0
Canonical exit: 7 Jun 2023 (T+90)
300,488 shares@ US$1.10020.5% of flowCommon StockSEC:0000933430-22-000011:0
Canonical exit: 15 Mar 2023 (T+90)
25 of 40 declarations
About Whitmore Bradford T
WHITMORE BRADFORD T is Director at Ultralife CORP. The record shows 40 filings in total, and the sampled recent filings run from 2016-02-10 to 2026-03-16, with buys of EUR 13652990 and sells of EUR 29290545. The largest transactions in that sample include NANOPHASE TECHNOLOGIES Corp, SOLESENCE, INC. and Clearside Biomedical, Inc., with a sale of EUR 28695387.22003782 on 2021-12-23 at NANOPHASE TECHNOLOGIES Corp and a buy of EUR 9228030.039998429 on 2025-06-02 at SOLESENCE, INC.
